NovoCure Limited Stock Deutsche Boerse AG
Stocks
038
JE00BYSS4X48
Medical Equipment, Supplies & Distribution
|
Market Closed -
Deutsche Boerse AG
02:03:27 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 14.56 EUR | -1.72% |
|
-0.88% | +32.89% |
| 07-24 | Wedbush Adjusts Price Target on NovoCure to $20 From $18, Maintains Neutral Rating | MT |
| 07-23 | NovoCure Limited, Q2 2026 Earnings Call, Jul 23, 2026 |
| Market Cap | 2.12B 1.82B 1.7B 1.56B 2.93B 203B 2.98B 20.03B 7.84B 102B 7.96B 7.78B 336B | P/E 2026 * |
-14.6x | P/E 2027 * | -22.3x |
|---|---|---|---|---|---|
| Enterprise Value | 2.01B 1.73B 1.61B 1.48B 2.78B 192B 2.83B 19.03B 7.45B 96.54B 7.56B 7.4B 319B | EV / Sales 2026 * |
2.77x | EV / Sales 2027 * | 2.37x |
| Free-Float |
90.04% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: NovoCure Limited
| 1 day | -1.72% | ||
| 1 week | -0.88% | ||
| Current month | +12.08% | ||
| 1 month | +4.45% | ||
| 3 months | -0.38% | ||
| 6 months | +61.15% | ||
| Current year | +32.89% |
| 1 week | 14.32 |  | 14.96 |
| 1 month | 12.64 | | 17.24 |
| Current year | 8.12 | | 17.24 |
| 1 year | 8.12 | | 17.24 |
| 3 years | 8.12 | | 32.57 |
| 5 years | 8.12 | | 144.6 |
| 10 years | 5.18 | | 203.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Frank Leonard
CEO | Chief Executive Officer | 46 | 2025-11-30 |
| Director of Finance/CFO | 52 | 2024-12-31 | |
Moshe Giladi
CTO | Chief Tech/Sci/R&D Officer | - | 2023-01-16 |
| Director | Title | Age | Since |
|---|---|---|---|
Asaf Danziger
BRD | Director/Board Member | 59 | 2011-12-31 |
Bill Doyle
CHM | Chairman | 63 | 2008-12-31 |
Kin Yip Leung
BRD | Director/Board Member | 64 | 2011-08-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.72% | -0.88% | - | - | 2.01B | |
| +0.64% | +0.17% | +28.00% | +30.10% | 12.79B | |
| +1.45% | +2.13% | +19.31% | +33.61% | 6.87B | |
| -3.12% | +1.92% | +47.49% | +44.94% | 6.82B | |
| +4.44% | +2.22% | - | - | 5.44B | |
| +1.73% | +4.92% | -20.64% | +62.13% | 4.7B | |
| -0.54% | -3.61% | -27.41% | -23.16% | 3.85B | |
| +5.57% | +3.06% | +50.54% | -41.38% | 2.01B | |
| -0.97% | -5.65% | +48.20% | -8.98% | 1.66B | |
| -2.73% | -1.11% | -31.76% | +121.99% | 1.63B | |
| Average | +0.27% | +0.13% | +14.22% | +27.41% | 5.09B | |
| Weighted average by Cap. | +0.53% | +0.55% | +18.38% | +30.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 726M 623M 581M 533M 1B 69.38B 1.02B 6.86B 2.69B 34.79B 2.73B 2.67B 115B | 804M 690M 644M 591M 1.11B 76.88B 1.13B 7.6B 2.98B 38.56B 3.02B 2.95B 127B |
| Net income | -142M -122M -114M -104M -196M -13.58B -200M -1.34B -526M -6.81B -533M -522M -22.51B | -84.8M -72.74M -67.92M -62.32M -117M -8.11B -119M -801M -314M -4.06B -318M -311M -13.44B |
| Net Debt | -105M -90.48M -84.49M -77.52M -146M -10.08B -148M -997M -390M -5.06B -396M -387M -16.72B | -210M -180M -168M -154M -290M -20.06B -295M -1.98B -777M -10.06B -788M -771M -33.27B |
| Date | Price | Change |
|---|---|---|
| 26-08-19 | €14.57 | -1.72% |
| 26-08-18 | €14.82 | +2.81% |
| 26-08-17 | €14.42 | -2.37% |
| 26-08-14 | €14.77 | -1.34% |
| 26-08-13 | €14.97 | -0.27% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NVCR Stock
- 038 Stock
Select your edition
All financial news and data tailored to specific country editions
